Late-life depression is known to be associated with specific clinical features, such as cognitive impairments, it typically has a poor outcome and is a risk factor for dementia. Vascular factors have been implicated in its aetiology, 1 but neuroinflammation has not been well studied despite being a highly plausible mechanism and potentially tractable target. We have previously shown an increase in inflammatory cytokines in the blood in older individuals with depression.
0.460.4 mm, 2 mm slice thickness, TR = 6420 ms, TE = 11 ms, flip angle 160). Within 4 months of MRI scans, PET imaging was performed on a GE Advance scanner (GE Healthcare, Waukesha, Wisconsin) for 75 min following bolus intravenous injection of [ 11 C]PK11195 (500 MBq), with a pre-injection 15 min 68 Ge/ 68 Ga transmission scan used for attenuation correction.
To estimate TSPO binding site density, non-displaceable binding potential (BP ND ) was determined from [
11 C]PK11195 PET data with the guidance of T 1 weighted MRI. 5 Regional white matter hyperintensity (WMH) volumes were segmented and quantified using T 2 FLAIR images. T 2 hippocampal coronal scans were manually segmented for cornu ammonis 1 (CA1), CA2, CA3/dentate gyrus, and measured for subiculum and entorhinal thickness. (See online supplement DS1 for detailed methods of PET analysis as well as WMH and hippocampal segmentation.)
As a result of the relatively small sample size in the depression group, we did not assume Gaussian data distributions. Grouplevel statistical comparisons of regional [
11 C]PK11195 PET BP ND as well as demographic, cognitive, blood, white matter lesion and hippocampal subfields data were performed using non-parametric Mann-Whitney U-test. Chi-squared test was used to test for gender differences between groups. In addition, regional [ 11 C]PK11195 BP ND data were also analysed using Monte Carlo randomisation tests to obtain P-values for each participant. (See online supplement DS1 for further details.) Results are reported without correction for multiple comparisons, noting that the primary outcome measure related to our principal hypothesis was [ 11 C]PK11195 BP ND in limbic cortical regions associated with depression and dementia.
Results
The two groups did not differ in age, gender ratio, education or global cognition (Mini-Mental State score 6 ) but the depression group had significantly higher blood CRP levels than controls (mean CRP: depression group 18.8 mg/L, control group 1.2 mg/L; P = 0.002) and a trend in Montgomery-Å sberg Depression Rating Scale 7 score (depression group 10.0, control group 4.0; W = 13.5, P = 0.065).
Although largely recovered from their depression at time of imaging, at the group level, participants with depression had The depression group showed trends for more extensive WMH in both periventricular (depression group 7.33 ml, control group 3.74 ml; W = 13, P = 0.059) and deep (depression group 1.85 ml, control group 0.73 ml; W = 15, P = 0.095) white matter. We found a significant reduction of CA1 area in the coronal plane (depression group 22.09 mm 2 , control group 24.90 mm 2 ; W = 52, P = 0.019) and subiculum thickness (depression group 1.73 mm, control group 1.95 mm; W = 56, P = 0.004) in the depression group. (See online supplement DS2 for additional demographic, cognitive, WMH and volumetric results.)
Discussion
We found evidence of both central and peripheral inflammation in older individuals with depression, including changes in the anterior cingulate and medial temporal lobe, which play a key role in the regulation of mood and cognitive functioning. 8 Damage in these areas is linked with an elevated risk of dementia. 9 Increased [ 11 C]PK11195 binding in people with depression could be associated with cerebrovascular disease and white matter lesions, reported in the current and previous studies, 10 although some controls also had a similar burden of WMH with normal levels of [ 11 C]PK11195 binding in subgenual anterior cingulate cortex and parahippocampus (online Fig. DS5 ). It is notable that [ 11 C]PK11195 BP ND showed the greatest effect size compared with other modalities, with a 300% increase from controls (v. 150% for WMH and 10% for hippocampal atrophy), suggesting a strong biomarker potential for late-life depression. There was no major cognitive impairment in our cohort, although the depression group showed significant atrophy in the hippocampus and subiculum, which have been shown to correlate with greater risk of cognitive impairment and Alzheimer's disease. 11 In addition, the hippocampus is a key component in the hypothalamic-pituitary-adrenal (HPA) axis. Increases in cytokine levels can lead to increases in oxidative stress and glucocorticoid as well as decreases in serotonin and other neurotransmitters in HPA resulting in impaired mood and cognition.
12,13
Our results were not corrected for multiple comparisons, and further replication is required in a larger cohort. However, the large effect size of [ 11 C]PK11195 was in keeping with our principal hypothesis and was supported by both a primary group-level test and secondary individual statistical tests. Cross-sectional studies provide limited information about whether neuroinflammation was the cause or consequence of neuronal damage in affected brain areas, so future longitudinal studies are needed. In conclusion, we suggest that neuroinflammation may be an important mechanism in late-life depression and merits further investigation as a potential target for novel therapeutics in a condition that responds poorly to conventional antidepressant therapy. (http://www.bic.mni.mcgill.ca/ServicesAtlases/HomePage). Then, the BP ND was transferred to Z-score with respect to the control group after non-brain areas (identified as not white or grey matter) were removed using SPM tissue class segments.
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T2 FLAIR: Segmentation and Quantification of White Matter Hyperintensities
Based on T2 FLAIR scans, individual white matter hyperintensity (WMH) maps were segmented using the Lesion Segmentation Toolbox in Statistical Parametric Mapping 12 (SPM: Wellcome
Institute of Neurology, University College London, UK). The technical details have been previously described 2 and this method has been shown to yield a high agreement with semi-manual lesion volume estimation. 3 After the segmentation of lesion maps, a trained operator (S.G.) manually inspected and corrected the segmentations while blinded to group diagnosis. An in-house script 4 was then used to quantify periventricular (PvWMH), and deep WMH volumes, as well as total WMH. In addition, lobar WMH in bilateral frontal, temporal, parietal, and occipital regions were also calculated.
T1 Weighted: Voxel-based Morphometry and ROI Analysis of Grey Matter Volumes
Individual T1-weighted volumetric images were processed using an optimised voxel-based morphometry (VBM) (http://dbm.neuro.uni-jena.de) within SPM. T1-weighted images were first biascorrected and segmented into grey matter (GM), white matter (WM), and cerebrospinal fluid (CSF)
partitions, and then affine normalised into MNI space. GM probability maps were modulated (intensity corrected for local volumetric changes induced during normalisation), followed by smoothing with an 8-mm full width at half maximum kernel. VBM analysis of GM differences was performed with a twosample T-test, controlling for Total Intracranial Volume (TIV: calculated as the sum of total volumes of the GM, WM and CSF partitions). Analyses were restricted to the GM mask of the template, thresholded at 10% GM probability. Results were assessed at a statistical threshold of p<0.001
uncorrected. We did not perform a conservative multiple comparison correction given the small sample, particularly in the LLD group. From the modulated GM images, we used the Hammers atlas, ) of specific regions of interests in the medial temporal lobe and the cingulate regions. Between-group differences in volumetric data were compared using ANCOVA while correcting for TIV.
T2 Weighted: Hippocampal Subfields Analysis
Hippocampal subfields were segmented manually using the high resolution (0.4 mm x 0.4 mm) T2
weighted MRI data. In order to increase the signal to noise ratio we acquired two images for each subject and aligned them before averaging to produce a final image. The averaged images for each subject were then analysed by two raters (L.H. and S.S.), blinded to the diagnosis and subject characteristics, using an established manual approach, in which the hippocampi and subfields CA1, CA2, CA3/DG were traced on the 3 coronal slices directly posterior to the head of hippocampus; 6, 7 see Fig. DS1 .
The subiculum thickness (see Fig. DS1 ) was measured at the point immediately before it joined the medial hippocampus on the three slices that had hippocampal traces made. The entorhinal cortex (ERC) was measured at the same point on the first slice of the hippocampal tracings and then the two slices anterior to this (in the hippocampal head) with the line drawn perpendicular to the inferior border of the ERC. The values for the subfield area, the ERC and subiculum thickness were averaged across the left and right hemispheres and the three image slices analysed.
We assessed the intra-rater reliability of the tracings by repeating the measurements with the same rater one month after the initial tracings. It was performed on a test dataset of 3 AD, 3 MCI and 3 control subjects. (One control subject in the test dataset is a subject in our control group.) As with the initial tracing, the rater was blinded to the diagnosis when repeating the procedure a month later. For inter-rater reliability, both raters traced the same test dataset of 9 subjects. We measured the percentage difference in measurements and Intraclass Correlation Coefficient (ICC), using a two-way random model for absolute agreement of measurements.
Individual level Monte Carlo randomisation test for regional [ 11 C]PK11195 PET data
In clinical practice, it is essential to obtain information about each individual patient. So, in addition to the group comparison, we have performed an additional individual level analysis comparing each subject to the rest of the population. This analysis took advantage of the relatively large control group (N=13) and derived a set of p-values for every subject including both controls and LLD subjects. This kind of randomisation test was widely used in functional MRI analysis (such as those statistical algorithms implemented in FSL 7 ) and to the analysis of EEG data in a lie detection scenario, in which discriminating guilty information at single subject level is particularly critical 8, 9 . The analysis procedure was as the follows:
1. Leave one subject S out;
2. Compute the mean BP ND of the opposite group to S; 3. Compute the distance (or difference) between the mean BP ND and the BP ND of subject S; call this distance d;
4. Randomly permute the group labels among all subjects except for S. This is to simulate the null hypothesis in which the BP ND for controls and patients would be sampled from the same distribution, i.e. group labels can be arbitrarily exchanged.
5. Compute the mean of the opposite group based on the permuted data, and the distance between the mean and the subject S. Call the new distance ds;
6. Repeat step 4 and step 5 for 10,000 times to build a null distribution of ds; (See Fig. DS2 for an example null distribution for parahippocampus ROI in subject LLD5.)
7. The percentage of times when ds is larger than d shows the likelihood of false positive, so can be converted to a p-value for subject S.
We have performed the above test for both subgenual anterior cingulate and parahippocampus ROIs, and the two p-values were further combined using the Stouffer's methods into a single p-value for each subject.
Supplement DS2
RESULTS
Subject Characteristics and Clinical Measurements
Depressed subjects (LLD) and controls (Con) did not differ in age, sex ratio, education or global cognition but had significantly higher blood CRP levels than controls, and a trend in Montgomery- Table DS1 .) Table DS2 shows the previous history of depressive episodes for the LLD subjects.
Åsberg Depression Rating Scale (MADRS). (See
White Matter Lesions
We found marginally increased WMH volumes in subjects with LLD in both periventricular and deep white matter. In terms of lobar distribution, the majority of WMH were in frontal and parietal regions, with temporal and occipital areas relatively spared compared with controls; see Table DS3 . However, we found that white matter lesions were common in both controls and LLD subjects largely due to the age range of our subjects.
Grey Matter Volume
In the whole brain voxel wise analysis, we found bilateral hippocampal, right fusiform, right frontal and bilateral precuneus atrophy in LLD subjects compared with controls (controlled for age, sex, years of education and TIV but uncorrected at p < 0.001; not significant after FWE/FDR corrections); see Fig.   DS3 . In the ROI analysis using the modified Hammers atlas, we found reduction in GM volume in right hippocampal in LLD (controlled for age, sex, years of education and TIV but uncorrected for multiple comparisons); see Table DS4 .
Hippocampal Segmentation Test-retest Reliability
The reliability of intra-and inter-rater measurements was comparable to what is found in the literature, 5, 6 with differences in the CA1, CA2 and CA3/DG areas and subiculum and ERC thickness below 13%, which is regarded as highly consistent. The intra-rater reliability was generally better than the inter-rater reliability in terms of both percentage size differences and ICC; see Table DS5 .
Hippocampal Subfields
Using T2 weighted scans optimised for hippocampal regions, we found significant atrophy in CA1 and subiculum areas in the medial temporal lobe, and a marginally atrophic CA2 in subjects with LLD compared with controls, see Table DS6 . This is consistent with both our GM volume analysis based on T1 weighted scans and prior research.
Individual level results for [
C]PK11195 BP ND
Using the Monte Carlo methods, we found that all LLD subjects have significantly increased Table DS7 .
This result based on a more rigorous nonparametric statistical test that makes minimum assumption about the data showed a consistent finding with the group level inference reported in the main text.
So, we can be more confident that the association in [ providing what is effectively a large sample size when accumulating across replications and the effectiveness of the method at the individual-level carries over to a larger sample.
Age and Disease Duration Effects
Although not significant, LLD subjects were 5 years older than controls on average. Due to the small sample size, we could not remove the younger controls to match the age between groups, or control age effectively in the statistical test. However, we found no correlation between age and the 
